Brand Name: ZIIHERA. Generic Name: (zanidatamab-hrii). It is used to treat treat adults who have a type of bile duct (cholangiocarcinoma) or gallbladder cancer called biliary tract cancer (BTC).
It is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed. ZIIHERA is a bispecific HER2-directed antibody indicated for the treatment of adults with previously treated, unresectable or metastatic HER2-positive (IHC 3+) biliary tract cancer (BTC), as detected by an FDA-approved test.
| Brand Name: | ZIIHERA |
| Generic Name: | zanidatamab-hrii |
| Strength: | • For injection: 300 mg lyophilized powder in a single-dose vial. |
| Manufacturer: | Jazz Pharmaceuticals, Inc. |
| Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “ZIIHERA (zanidatamab-hrii) Injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.